ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea
· Delayed Price · Currency is KRW 871.00
+2.00 (0.23%)
At close: Mar 6, 2026
KOSDAQ:034940 Revenue
ChoA Pharmaceutical Co., LTD. had revenue of 15.48B KRW in the quarter ending September 30, 2025, with 1.59% growth. This brings the company's revenue in the last twelve months to 60.50B, down -1.56% year-over-year. In the year 2024, ChoA Pharmaceutical Co., LTD. had annual revenue of 62.69B, down -0.44%.
Revenue (ttm)
60.50B
Revenue Growth
-1.56%
P/S Ratio
0.42
Revenue / Employee
224.91M
Employees
269
Market Cap
25.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.69B | -280.00M | -0.44% |
| Dec 31, 2023 | 62.97B | -5.91B | -8.57% |
| Dec 31, 2022 | 68.88B | 11.32B | 19.66% |
| Dec 31, 2021 | 57.56B | -7.80B | -11.93% |
| Dec 31, 2020 | 65.36B | -2.18B | -3.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharmsville | 13.36B |
| Hurum | 95.37B |
| Daesung Microbiological Labs. | 25.86B |
| Seoul Pharma | 52.43B |
| BIFIDO | 18.65B |
| WooGene B&G | 54.77B |
| Union Korea Pharm | 33.83B |
| HLscience | 18.10B |